Role of toll-like receptors in cancer immunotherapy– a review

Role of toll-like receptors in cancer immunotherapy– a review

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Dades bibliogràfiques
Autor principal:	Khan, Rezia Nowrin
Altres autors:	Chowdhury, Namara Mariam
Format:	Thesis
Idioma:	English
Publicat:	Brac University 2021
Matèries:	Toll-like receptors (TLRs) Cancer progression TLR-ligands Anti-cancer therapeutics Signaling Cancer > Immunotherapy
Accés en línia:	http://hdl.handle.net/10361/15525

Ítems similars

Immunotherapy in the Management of Lung Cancer
per: Tasnim, Humayra
Publicat: (2022)

Current practice and approaches of immunotherapy in Cancer treatment
per: Khondokar, Faiza
Publicat: (2022)

A review on triple-negative breast cancer and its potential treatment
per: Niasa, Jannatul Ferdous
Publicat: (2023)

Role of statins as antagonists of SPARC in gastric cancer
per: Shahmat, Rad
Publicat: (2019)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
per: Abir, Shifaty Nur
Publicat: (2024)

Immunotherapy in the treatment of renal cancer
per: Shimu, Sumaya
Publicat: (2022)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
per: Hasan, Amit
Publicat: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
per: Jahan, Nusrat
Publicat: (2024)

Statistics and informatics in molecular cancer research

Use of combination of satins as antagonists of SPARC in stomach cancer: an in silico study
per: Rashed, Sadman Sakib Bin
Publicat: (2019)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
per: Rahman, Sanjida
Publicat: (2024)

A review on potential role of cannabinoids as therapeutic agents in different types of cancer
per: Roy, Hredita
Publicat: (2018)

A review on potential of PARP inhibitors in the treatment of prostate cancer
per: Islam, Saidul
Publicat: (2022)

Recent advancement on breast cancer detection and treatment
per: Rahman, Sanjida
Publicat: (2023)

Stem cell in cancer disease cure vs cause
per: Chowdhury, Marisha Mansur
Publicat: (2023)

Cancer risk factors: a critical review
per: Tabassum, Tahsina
Publicat: (2017)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
per: Nawar, Anika
Publicat: (2019)

A review paper on Nanotechnology based strategies in the treatment of cancer
per: Rahman, Samia
Publicat: (2022)

CAR-T cell Therapy in B-cell Lymphoma
per: Faruk, Asef
Publicat: (2020)

Dendritic cell vaccine for the treatment of cancer
per: Haque, Tanzila
Publicat: (2023)

Epigenetic therapy in cancer
per: Abid, Md. Shadman Ridwan
Publicat: (2021)

A systematic review on the comparison of FOLFIRI and FOLFOX based chemotherapies in the treatment of metastatic colorectal Cancer
per: Islam, Nurjahan
Publicat: (2022)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
per: Shobnam, Sohana
Publicat: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
per: Pial, Sazia Afrin
Publicat: (2018)

Bioinformatics Analysis Reveals miR-98-5p as a potential Inhibitor of Tumor cell proliferation and metastasis in Colorectal Cancer by targeting the FZD3 receptor of the Wnt signaling pathway
per: Kenneth, Mutebi John
Publicat: (2022)

Stem cells as therapeutic carrier in cancer treatment
per: Anika, Mysha Yeasmin
Publicat: (2022)

Molecules associated with the development of lung cancer
per: Rahman, Adree, et al.
Publicat: (2023)

Current perspectives on cancer prevention strategies: implications for Bangladesh
per: Afrin, Sajia
Publicat: (2017)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
per: Flora, Sanzida Alam
Publicat: (2024)

Point-of care diagnostic devices in cancer detection
per: Yasmin, Rizwana
Publicat: (2022)

Breast cancer awareness seminars
per: Anwer Khan Modern Medical College
Publicat: (2016)

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
per: Choki, Kinley
Publicat: (2024)

Molecular biology of cancer : mechanisms, targets, and therapeutics /
per: Pecorino, Lauren
Publicat: (2012)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
per: Hossain, Safa Binte
Publicat: (2019)

Potential of nanoparticles as a topical drug delivery system for skin cancer: a review
per: Islam, Karima
Publicat: (2022)

Current scenario of Cancer in Dhaka City, Bangladesh
per: Natth, Bratakatha
Publicat: (2016)

Targeting BRAFV600E in the treatment of CRC
per: Roja, Mashwiyat Samrin
Publicat: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
per: Jeba, Joynob
Publicat: (2017)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
per: Raihan, Dilraj
Publicat: (2024)

A comprehensive review on drug repurposing in cancer treatment
per: Sarkar, Onusree
Publicat: (2024)